Journal article
Advanced Analgesic Drug Delivery and Nanobiotechnology
Drugs (New York, N.Y.), Vol.77(10), pp.1069-1076
07/01/2017
DOI: 10.1007/s40265-017-0744-y
PMCID: PMC5488073
PMID: 28470586
Abstract
Transdermal administration of analgesic medications offers several benefits over alternative routes of administration, including a decreased systemic drug load with fewer side effects, and avoidance of drug degradation by the gastrointestinal tract. Transdermal administration also offers a convenient mode of drug administration over an extended period of time, particularly desirable in pain medicine. A transdermal administration route may also offer increased safety for drugs with a narrow therapeutic window. The primary barrier to transdermal drug absorption is the skin itself. Transdermal nanotechnology offers a novel method of achieving enhanced dermal penetration with an extended delivery profile for analgesic drugs, due to their small size and relatively large surface area. Several materials have been used to enhance drug duration and transdermal penetration. The application of nanotechnology in transdermal delivery of analgesics has raised new questions regarding safety and ethical issues. The small molecular size of nanoparticles enables drug delivery to previously inaccessible body sites. To ensure safety, the interaction of nanoparticles with the human body requires further investigation on an individual drug basis, since different formulations have unique properties and side effects.
Details
- Title: Subtitle
- Advanced Analgesic Drug Delivery and Nanobiotechnology
- Creators
- Nicoleta Stoicea - The Ohio State University Wexner Medical CenterJuan Fiorda-Diaz - The Ohio State University Wexner Medical CenterNicholas Joseph - The Ohio State University Wexner Medical CenterMuhammad Shabsigh - The Ohio State University Wexner Medical CenterCarlos Arias-Morales - The Ohio State University Wexner Medical CenterAlicia A. Gonzalez-Zacarias - The Ohio State University Wexner Medical CenterAna Mavarez-Martinez - The Ohio State University Wexner Medical CenterStephen Marjoribanks - The Ohio State University Wexner Medical CenterSergio D. Bergese - The Ohio State University Wexner Medical Center
- Resource Type
- Journal article
- Publication Details
- Drugs (New York, N.Y.), Vol.77(10), pp.1069-1076
- Publisher
- Springer International Publishing
- DOI
- 10.1007/s40265-017-0744-y
- PMID
- 28470586
- PMCID
- PMC5488073
- ISSN
- 0012-6667
- eISSN
- 1179-1950
- Language
- English
- Date published
- 07/01/2017
- Academic Unit
- Anesthesia
- Record Identifier
- 9984656601202771
Metrics
15 Record Views